Laryxin Menthol (Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride Monohydrate)

Chlorhexidine dihydrochloride acts by binding to bacterial cell walls and disrupting membrane integrity, leading to leakage of intracellular components and cell death. This broad‑spectrum activity makes it effective against many Gram‑positive and Gram‑negative organisms commonly found in the oral cavity.

The dosage of Laryxin Menthol is determined by the prescribing healthcare professional based on the patient’s condition, age and severity of symptoms. The prescriber will specify the amount to be applied, frequency and duration of treatment.

Safety data for Laryxin Menthol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with alternatives such as benzydamine or povidone‑iodine, Laryxin Menthol offers the combined benefit of an antiseptic (chlorhexidine) and a rapid‑acting local anaesthetic (lidocaine). This dual action can provide both infection control and immediate pain relief, whereas many other agents provide only one of these effects.

Store Laryxin Menthol at room temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Ensure the cap is tightly closed to maintain product stability and prevent contamination.

Laryxin Menthol is applied directly to the affected oral mucosa. The patient should swish a measured amount for the time recommended by the prescriber, then expectorate or retain as instructed, allowing the solution to coat the throat and oral tissues for optimal effect.

Serious risks include allergic reactions such as angioedema or anaphylaxis, severe mucosal ulceration, prolonged numbness indicating possible systemic lidocaine absorption, and rare dermatologic conditions like Stevens‑Johnson syndrome. Immediate medical attention is required if any of these occur.

Individuals with known hypersensitivity to chlorhexidine, lidocaine or any excipients in the formulation should avoid using Laryxin Menthol. It is also contraindicated in patients with extensive oral lesions unless directed by a clinician, and caution is advised for those with certain cardiac conduction disorders.